Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
Clinical trial NCT03563846 · COMPLETED
Trial details
- NCT number
- NCT03563846
- Sponsor
- Ritter Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2018-04-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.